Shimadzu Corp (7701):企業の財務・戦略的SWOT分析

◆英語タイトル:Shimadzu Corp (7701) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0052
◆発行会社(調査会社):GlobalData
◆発行日:2019年11月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shimadzu Corp (7701) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shimadzu Corp (Shimadzu) is a manufacturer of precision instruments, measuring instruments and medical equipment. The company’s product portfolio includes high performance liquid chromatographs (HPLC), spectrometers, carbon analyzer, X-ray systems, inspection systems, semiconductor manufacturing equipment, liquid transmission equipment, hydraulic equipment, onboard flight management systems, flight control systems, and cockpit display systems. Shimadzu offers products to wide range of industries such as healthcare (hospitals and clinics), pharmaceutical, chemical, aeronautic, food and beverages, education, construction and other industries. The company along with its subsidiaries markets products through a network of distributors in the Americas, Europe, Asia-Pacific, the Middle East and Africa. Shimadzu is headquartered in Kyoto, Japan.

Shimadzu Corp Key Recent Developments

Jul 05,2019: Determining the differentiation status of cells by an ultra fast liquid chromatograph mass spectrometer
May 29,2019: New Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer provides fast, high-sensitive measurements through an ultra-compact design
May 15,2019: Shimadzu selects Mentor’s Xpedition PCB design-through-manufacturing flow as its global standard
May 09,2019: Shimadzu’s new C2MAP-2030 Automatic Pretreatment System for cell culture media analysis Enables Flexible System operation according to a given laboratory environment
Mar 20,2019: Shimadzu releases new Multi-Omic Data Analysis Package and relevant method packages in cooperation with the Systems Biology Institute and Osaka University

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Shimadzu Corp – Key Facts
Shimadzu Corp – Key Employees
Shimadzu Corp – Key Employee Biographies
Shimadzu Corp – Major Products and Services
Shimadzu Corp – History
Shimadzu Corp – Company Statement
Shimadzu Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Shimadzu Corp – Business Description
Business Segment: Aircraft Equipment
Overview
Performance
Business Segment: Analytical and Measuring Instruments
Overview
Performance
Business Segment: Industrial Machinery
Overview
Performance
Business Segment: Medical Systems
Overview
Performance
Business Segment: Other
Performance
Business Segment: Other Asian Countries
Target Markets
Geographical Segment: China
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: Other Asian Countries
Performance
Geographical Segment: The Americas
Performance
R&D Overview
Shimadzu Corp – SWOT Analysis
SWOT Analysis – Overview
Shimadzu Corp – Strengths
Shimadzu Corp – Weaknesses
Shimadzu Corp – Opportunities
Shimadzu Corp – Threats
Shimadzu Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Shimadzu Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Shimadzu Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Shimadzu Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 05, 2019: Determining the differentiation status of cells by an ultra fast liquid chromatograph mass spectrometer
May 29, 2019: New Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer provides fast, high-sensitive measurements through an ultra-compact design
May 15, 2019: Shimadzu selects Mentor’s Xpedition PCB design-through-manufacturing flow as its global standard
May 09, 2019: Shimadzu’s new C2MAP-2030 Automatic Pretreatment System for cell culture media analysis Enables Flexible System operation according to a given laboratory environment
Mar 20, 2019: Shimadzu releases new Multi-Omic Data Analysis Package and relevant method packages in cooperation with the Systems Biology Institute and Osaka University
Mar 15, 2019: Shimadzu’s new Nexera UHPLC series with AI and IoT enhancements sets industry standard for intelligence, efficiency and design
Feb 27, 2019: The LCMS-9030 Quadrupole Time-of-Flight Mass Spectrometer Wins an iF DESIGN AWARD 2019
Feb 27, 2019: The LCMS-9030 quadrupole time-of-flight mass spectrometer wins an iF DESIGN AWARD 2019
Jan 24, 2019: Shimadzu announces a new research facility to drive innovation further as part of the Shimadzu Technology Research Laboratory expansion
Jan 11, 2019: Shimadzu’s new preparative purification LC System provides high efficiency, saves space, and enables multi-sample processing
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Shimadzu Corp, Key Facts
Shimadzu Corp, Key Employees
Shimadzu Corp, Key Employee Biographies
Shimadzu Corp, Major Products and Services
Shimadzu Corp, History
Shimadzu Corp, Other Locations
Shimadzu Corp, Subsidiaries
Shimadzu Corp, Joint Venture
Shimadzu Corp, Key Competitors
Shimadzu Corp, Ratios based on current share price
Shimadzu Corp, Annual Ratios
Shimadzu Corp, Annual Ratios (Cont...1)
Shimadzu Corp, Annual Ratios (Cont...2)
Shimadzu Corp, Interim Ratios
Shimadzu Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Shimadzu Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
Shimadzu Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Shimadzu Corp, Performance Chart (2015 - 2019)
Shimadzu Corp, Ratio Charts
Shimadzu Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
Shimadzu Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Shimadzu Corp (7701):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cocrystal Pharma Inc (COCP):製薬・医療:M&Aディール及び事業提携情報
    Summary Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline produc …
  • Liberty Holdings Ltd:企業の戦略・SWOT・財務情報
    Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ZyGEM NZ Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ZyGEM NZ Ltd (ZyGEM), a subsidiary of MicroGEM International PLC is a drug development company that develops and technologies for life science, agricultural and horticultural industries. The company produces DNA extraction products, and enzymes used in diagnostics, molecular biology and indu …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Polyphor AG (POLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Polyphor AG (Polyphor) is a clinical stage biopharmaceutical company that discovers and develops antibiotics and other specialty pharma products for severe or life-threatening diseases. The company offers hematopoietic stem cells for multiple myeloma patients, Pseudomonas infections and prot …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • MiMedx Group Inc (MDXG):企業の製品パイプライン分析
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T cell epitope database is used for screening amino acid sequences from antibo …
  • GarrettCom, Inc.:企業の戦略的SWOT分析
    GarrettCom, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Omega Pharma NV:企業の戦略・SWOT・財務情報
    Omega Pharma NV - Strategy, SWOT and Corporate Finance Report Summary Omega Pharma NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Oragenics Inc (OGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lan …
  • Vista Outdoor Inc:戦略・SWOT・企業財務分析
    Vista Outdoor Inc - Strategy, SWOT and Corporate Finance Report Summary Vista Outdoor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kindred Healthcare, Inc.:戦略・SWOT・企業財務分析
    Kindred Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kindred Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Carl Zeiss Meditec AG (AFX):製品パイプライン分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • Genisphere LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …
  • SBM Offshore NV (SBMO):石油・ガス:M&Aディール及び事業提携情報
    Summary SBM Offshore NV (SBM Offshore) is a floating production solutions provider for offshore oil and gas industry. The company designs supplies, installs and operates Floating Production, Storage and Offloading (FPSO) vessels. The company leases its FPSO vessels to its clients. It also undertakes …
  • Microbiotix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Microbiotix Inc (Microbiotix) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of infectious diseases. The company provides products for hepatitis C virus and human cytomegalovirus including HCV NS5B MBX-700, MBX-701 and MBX-400. It also provi …
  • Lidds AB (LIDDS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Proteomics International Laboratories Ltd (PIQ):医療機器:M&Aディール及び事業提携情報
    Summary Proteomics International Laboratories Ltd (Proteomics International) is a medical technology company that discovers new biopharmaceutical drugs. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and …
  • CompuGroup Medical SE:企業のM&A・事業提携・投資動向
    CompuGroup Medical SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CompuGroup Medical SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆